108 related articles for article (PubMed ID: 1963135)
1. Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.
Tangrea J; Edwards B; Hartman A; Taylor P; Peck G; Salasche S; Menon P; Winton G; Mellette R; Guill M
Control Clin Trials; 1990 Dec; 11(6):433-50. PubMed ID: 1963135
[TBL] [Abstract][Full Text] [Related]
2. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group.
Tangrea JA; Edwards BK; Taylor PR; Hartman AM; Peck GL; Salasche SJ; Menon PA; Benson PM; Mellette JR; Guill MA
J Natl Cancer Inst; 1992 Mar; 84(5):328-32. PubMed ID: 1738183
[TBL] [Abstract][Full Text] [Related]
3. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061
[TBL] [Abstract][Full Text] [Related]
4. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
[TBL] [Abstract][Full Text] [Related]
5. Patients' perceptions on participation in a cancer chemoprevention trial.
Tangrea JA; Adrianza ME; Helsel WE
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):325-30. PubMed ID: 1303133
[TBL] [Abstract][Full Text] [Related]
6. Isotretinoin does not prevent basal cell carcinoma.
Robinson JK; Salasche SJ
Arch Dermatol; 1992 Jul; 128(7):975-6. PubMed ID: 1626967
[No Abstract] [Full Text] [Related]
7. Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin.
Tangrea JA; Kilcoyne RF; Taylor PR; Helsel WE; Adrianza ME; Hartman AM; Edwards BK; Peck GL
Arch Dermatol; 1992 Jul; 128(7):921-5. PubMed ID: 1626958
[TBL] [Abstract][Full Text] [Related]
8. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
[TBL] [Abstract][Full Text] [Related]
9. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
10. Dose response of retinol and isotretinoin in the prevention of nonmelanoma skin cancer recurrence.
Clouser MC; Roe DJ; Foote JA; Harris RB; Alberts DS
Nutr Cancer; 2010; 62(8):1058-66. PubMed ID: 21058193
[TBL] [Abstract][Full Text] [Related]
11. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of isotretinoin in preventing the appearance of basal cell carcinomas in basal cell nevus syndrome.
Goldberg LH; Hsu SH; Alcalay J
J Am Acad Dermatol; 1989 Jul; 21(1):144-5. PubMed ID: 2745766
[No Abstract] [Full Text] [Related]
13. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of basal cell carcinoma with isotretinoin.
Peck GL; Gross EG; Butkus D; DiGiovanna JJ
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):815-23. PubMed ID: 6950957
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of basal cell carcinoma with oral isotretinoin.
Peck GL; DiGiovanna JJ; Sarnoff DS; Gross EG; Butkus D; Olsen TG; Yoder FW
J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):176-85. PubMed ID: 3165982
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
[TBL] [Abstract][Full Text] [Related]
17. Isotretinoin does prevent skin cancer.
Kraemer KH; DiGiovanna JJ; Peck GL
Arch Dermatol; 1993 Jan; 129(1):43. PubMed ID: 8420486
[No Abstract] [Full Text] [Related]
18. Design and recruitment for retinoid skin cancer prevention (SKICAP) trials. The Southwest Skin Cancer Prevention Study Group.
Moon TE; Levine N; Cartmel B; Bangert J; Rodney S; Schreiber M; Peng YM; Ritenbaugh C; Meyskens F; Alberts D
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):661-9. PubMed ID: 8547834
[TBL] [Abstract][Full Text] [Related]
19. Prospective, randomized, multicenter, double-blind placebo-controlled trial comparing adjuvant interferon alfa and isotretinoin with interferon alfa alone in stage IIA and IIB melanoma: European Cooperative Adjuvant Melanoma Treatment Study Group.
Richtig E; Soyer HP; Posch M; Mossbacher U; Bauer P; Teban L; Svolba G; Wolf IH; Fritsch P; Zelger B; Volc-Platzer B; Gebhart W; Mischer P; Steiner A; Pachinger W; Hintner H; Gschnait F; Rappersberger K; Pilarski P; Pehamberger H;
J Clin Oncol; 2005 Dec; 23(34):8655-63. PubMed ID: 16260701
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
